ASPN: financial statements from SEC — TradeAlmanac

ASPN

Aspen Aerogels, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	271m	453m
Cost of revenue	225m	270m
Gross profit	46m	183m
Research and development	13m	18m
Selling, general and administrative	56m	71m
Operating expenses	424m	128m
Operating income	−378m	55m
Pre-tax income	−387m	15m
Income tax	2m	2m
Net income	−390m	13m
Earnings per share	−4.73	0.17
Earnings per share, diluted	−4.73	0.17
Weighted average shares	82m	78m
Weighted average shares, diluted	82m	80m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	174m	157m	151m	168m	192m	221m	113m	91m
Receivables	36m	35m	69m

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	33m	46m
Depreciation and amortisation	45m	23m
Share-based compensation	9m	13m
Capital expenditure	37m	86m
Investing cash flow	−37m	−86m
Financing cash flow	−58m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)